Get started
Biogen Inc. 5.75% 15-MAY-2035Biogen Inc. 5.75% 15-MAY-2035Biogen Inc. 5.75% 15-MAY-2035

Biogen Inc. 5.75% 15-MAY-2035

No trades
See on Supercharts
Overview
Analysis News

BIIB6071069 chart


Full chart

Key terms


Outstanding amount
‪650.00 M‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
5.75% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
5.64%
Maturity date
May 15, 2035
Term to maturity
9 years

About Biogen Inc. 5.75% 15-MAY-2035


Issuer
Biogen, Inc.
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
biogen.com
Issue date
May 12, 2025
FIGI
BBG01TVS6994
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

BIIB6071069 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

BIIB6071069 news



See how Biogen, Inc. is moving with its highest-yielding bonds.